Drug Shortage Report for LYRICA
Report ID | 212590 |
Drug Identification Number | 02268418 |
Brand name | LYRICA |
Common or Proper name | pregabalin |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | PREGABALIN |
Strength(s) | 25MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 60 caps/bottle |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-12-27 |
Actual start date | 2023-12-16 |
Estimated end date | 2024-02-20 |
Actual end date | 2024-02-09 |
Shortage status | Resolved |
Updated date | 2024-02-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-02-29 | French | Compare |
v6 | 2024-02-29 | English | Compare |
v5 | 2024-01-10 | French | Compare |
v4 | 2024-01-10 | English | Compare |
v3 | 2023-12-28 | English | Compare |
v2 | 2023-12-06 | French | Compare |
v1 | 2023-12-06 | English | Compare |
Showing 1 to 7 of 7